Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

34M Americans know someone who died because they couldn’t afford healthcare

A shocking number of Americans know someone, either a friend or family member, in the past five years who died because they couldn’t afford to receive necessary medical treatment, according to a new Gallup and West Health study.

Thumbnail

CMS proposes more Medicaid oversight

CMS has proposed a new rule intended to increase oversight of the fiscal integrity of the Medicaid program. Specifically, the proposal would increase reporting on supplemental payments, clarify some Medicaid financing definitions and attempt to crack down on questionable financing mechanisms.

Thumbnail

How should AI be regulated?

As AI technologies have continued to evolve all over the world, it has become more and more evident that proper regulation is necessary.

Thumbnail

AI in Healthcare 2020 Leadership Survey Report: The Doctor Says

Sponsored by Pure Storage

AI is “very important” or “absolutely essential” to strategy and future plans (72%). Read more

Thumbnail

AI in Healthcare 2020 Leadership Survey Report: From the C-Suite

Sponsored by Pure Storage

 34% work for health systems “advanced” and “proficient” in AI. Read more

Thumbnail

2020 Medicare Part B premiums, Part A deductibles will rise

Medicare Part B premiums will be higher in 2020 than in 2019, while deductibles in Part A, which typically doesn’t have a premium, will also rise, according to CMS.

Thumbnail

AI in Healthcare 2020 Leadership Survey Report: About the Survey

Sponsored by Pure Storage

The AI in Healthcare team embarked on this survey to gain a deeper understanding of the current state of artificial and augmented intelligence in use and being planned across healthcare in the next few years. Read more

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.